| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Tpr2g2321 | ATGAGTGTAGATCTGAAGAAAACTGCCTCTAATGGCAATGAGAAAATGTTAATAACACAAGAACAGCAGGGAAAGATCAATGAGGTGAGAAGGTTAATCGGGCCACTGTCTGGTAAGGCATTCGTTTATTGTTCTGACACATCCATCACAAGGTATTTAAGGGCACGAAATTGGAATGTCAAGAAGGCGGCTAAAATGTTGAAGCAGACACTTAAATGGAGAGAAGAATATAAACCAGAAGAGATCCGCTGGGAAGATATTGCTCAAGAAGCAGAGACCGGAAAGATCTACAGATCAAATTATATTGACAAGCATGGGAGAACAGTACTTGTAATGAGACCTGCTCGTCAGAATTCGAAGTCAACAAAAGGACAAATTAAGTATTTGGTGTACTGCATGGAGAATGCTATTTTAAATCTTTCACCAGAACAGGAACAGATGGTCTGGCTGATTGATTTCCAGGGTTTCAATATGTCACACATATCTATCAAAGTGACACGCGAAACTGCCCATGTATTACAAGACCATTATCCTGAACGGCTGGGTCTGGCAATACTATACAATCCACCTAAAATCTTCGAACCATTCTTCACGATGGTAAAGCCCATATTAGAGACCAAGACTTATAACAAAGTCAAGTTCGGTTATTCCGATGATCAGAATACCAAGAAGATTATGGAGGATTTGTTTGATTTAGAGCATCTTGAATCTGCTTTCGGTGGGAATGATAATACACCATTTGACATAAATAAATATGCTGAGAGAATGAAAGAAGATGATAAGAAGATTCCTTCTTTCTGGACAAGGGAAATCTCACCATCTTCAGTCCCAATTGATGTTCCTTCTTTAGATTCGATTAAATTAGACACAGATTCTGATGCCTCTGACAATGAGAAAATAGTTTCTTCTTCTGACTCAGTTACTGATACTGGCTCCGTCGACCCTGATCAAAACTCAGTTATTCAAGAGGATCGGAATACGAGTGCTGCTATGCATTAG | 999 | 0.3924 | MSVDLKKTASNGNEKMLITQEQQGKINEVRRLIGPLSGKAFVYCSDTSITRYLRARNWNVKKAAKMLKQTLKWREEYKPEEIRWEDIAQEAETGKIYRSNYIDKHGRTVLVMRPARQNSKSTKGQIKYLVYCMENAILNLSPEQEQMVWLIDFQGFNMSHISIKVTRETAHVLQDHYPERLGLAILYNPPKIFEPFFTMVKPILETKTYNKVKFGYSDDQNTKKIMEDLFDLEHLESAFGGNDNTPFDINKYAERMKEDDKKIPSFWTREISPSSVPIDVPSLDSIKLDTDSDASDNEKIVSSSDSVTDTGSVDPDQNSVIQEDRNTSAAMH* | 333 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Tpr2g2321 | 332 | MobiDBLite | consensus disorder prediction | 289 | 332 | - | - | |
| Tpr2g2321 | 332 | PANTHER | CRAL-TRIO LIPID BINDING DOMAIN, CRAL/TRIO DOMAIN-CONTAINING PROTEIN-RELATED | 1 | 304 | - | - | |
| Tpr2g2321 | 332 | Pfam | CRAL/TRIO domain | 93 | 241 | IPR001251 | - | |
| Tpr2g2321 | 332 | PANTHER | GH16843P | 1 | 304 | - | - | |
| Tpr2g2321 | 332 | CDD | SEC14 | 92 | 242 | IPR001251 | - | |
| Tpr2g2321 | 332 | Gene3D | - | 3 | 271 | IPR036865 | - | |
| Tpr2g2321 | 332 | Pfam | CRAL/TRIO, N-terminal domain | 45 | 68 | IPR011074 | - | |
| Tpr2g2321 | 332 | SUPERFAMILY | CRAL/TRIO domain | 84 | 262 | IPR036865 | - | |
| Tpr2g2321 | 332 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 18 | 86 | IPR036273 | - | |
| Tpr2g2321 | 332 | MobiDBLite | consensus disorder prediction | 299 | 332 | - | - | |
| Tpr2g2321 | 332 | SMART | CRAL_TRIO_N_2 | 45 | 70 | IPR011074 | - | |
| Tpr2g2321 | 332 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 84 | 247 | IPR001251 | - | |
| Tpr2g2321 | 332 | PRINTS | Cellular retinaldehyde-binding protein signature | 48 | 70 | - | - | |
| Tpr2g2321 | 332 | PRINTS | Cellular retinaldehyde-binding protein signature | 164 | 185 | - | - | |
| Tpr2g2321 | 332 | PRINTS | Cellular retinaldehyde-binding protein signature | 197 | 216 | - | - | |
| Tpr2g2321 | 332 | SMART | sec14_4 | 90 | 244 | IPR001251 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Tpr2g2321 | Tpr-Chr2 | 27994483 | 27998841 | Dispersed/Wgd |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Tpr2g2321 | - | - | gmx:100777106 | 541.576 |